The Hidden Crisis of Diabetes in the Workplace: Beyond Sick Days and Spreadsheets
There’s a silent storm brewing in workplaces across Canada, and it’s not about AI or remote work policies. It’s diabetes. Personally, I think what makes this particularly fascinating is how diabetes has quietly become the second-largest driver of private drug spending, just behind inflammatory conditions. But here’s the kicker: it’s not just a health issue—it’s a productivity crisis in disguise. According to a recent report by Express Scripts Canada, diabetes claims among adults aged 18 to 44 jumped by 6% in 2025. That’s the core of the workforce, folks. And yet, we’re treating it like a series of isolated sick days rather than a systemic challenge.
The Mental Load of Chronic Management
One thing that immediately stands out is the mental toll of managing diabetes. It’s a 24/7 job, and the stress of it can make it incredibly difficult for employees to act when it matters most. Gina Kawak, director of pharmacy benefits at Manulife, hit the nail on the head when she said, ‘The challenge with diabetes is that it often gets more complex over time.’ What many people don’t realize is that diabetes isn’t just about blood sugar levels—it’s a multi-system condition that can lead to high blood pressure, nerve pain, and even cardiovascular issues. If you take a step back and think about it, this isn’t just a health problem; it’s a workplace productivity problem.
Predictable Risks, Preventable Crises
Here’s where it gets really interesting: the moments of risk in diabetes management are often predictable. Illnesses, even minor ones, can destabilize glucose levels and lead to emergency room visits. Dr. Marie-Philippe Morin, a specialist in internal medicine, pointed out that diabetic ketoacidosis (DKA) can develop rapidly during routine illnesses like the flu. What this really suggests is that we’re failing to connect the dots between health and productivity. Manulife’s data shows that while absence accounts for just 3% of lost time, reduced productivity accounts for a staggering 19%. That’s 46 lost working days per employee per year. In my opinion, this isn’t just a healthcare issue—it’s a leadership issue.
The Role of Early Intervention
From my perspective, the solution lies in early intervention. Kawak emphasized that when diabetes is managed early, there’s a better chance for fewer complications and slower progression. But here’s the catch: early intervention requires a shift in mindset. Employers, insurers, and clinicians need to stop reacting to crises and start building preventive strategies into the foundation of workplace health programs. Sensor-based glucose monitoring systems, like Abbott’s FreeStyle Libre, can drive behavioral change through real-time feedback. But, as Dr. Morin noted, coverage for these tools remains restricted to patients already on insulin. This raises a deeper question: are we prioritizing cost savings over long-term health and productivity?
The Workplace as a Health Partner
What makes this particularly fascinating is the role employers can play in diabetes management. Christine Than from Willis Towers Watson argued that workplace disruption is often the clearest signal of uncontrolled diabetes. Employees with poorly managed diabetes are more likely to make errors, and those errors can have real consequences. But intervention isn’t straightforward. Diabetes management sits at the intersection of workplace oversight and personal privacy. Emilie Vigneault-Simard, a specialized nurse practitioner, warned that organizations must build trust to avoid reinforcing stigma around chronic conditions. Personally, I think this is where the real challenge lies—balancing support with respect for individual boundaries.
The Broader Implications
If you take a step back and think about it, the implications of effective diabetes management go far beyond healthcare costs. It’s about creating a more stable, productive workforce. Manulife’s data shows that early dietitian engagement can reduce the likelihood of progressing to second-line therapy by 40% and lower cardiovascular risk. That’s a $400 per-employee reduction in combined drug and paramedical spend over two years. But what this really suggests is that investing in preventive care isn’t just a moral imperative—it’s a financial one. The opportunity is clear: by treating predictable risks as preventable events, employers and insurers can reshape outcomes for both costs and the workforce itself.
Final Thoughts
In my opinion, the diabetes crisis in the workplace is a wake-up call. It’s a reminder that health and productivity are inextricably linked. We can’t afford to treat diabetes as a series of isolated sick days. Instead, we need to rethink sick day management as a preventive strategy, equip employees with the tools they need, and foster a culture of early intervention. A detail that I find especially interesting is how this issue reflects broader trends in workplace health—we’re moving from reaction to anticipation. And that, I believe, is the future of workplace wellness.
